Просмотр исходного текста страницы A Leaked Secret For 17-DMAG (Alvespimycin) HCl Found

Statistical analysis was performed using SAS version 9.1 (SAS Institute Inc, Cary, NC). Normally distributed continuous variables are presented as mean?��?SD. Those variables not normally distributed are shown as median?��?interquartile range. Categorical variables are expressed as frequencies and percentages. Baseline characteristics were compared using Student's t test for parametric variables or the Mann�CWhitney U test when not normally distributed. Categorical variables were compared using chi-square test or Fisher's exact test as appropriate. From 03/2011 to 03/2012, there were a total of 470 STEMI system activations; CHap was used in 83 cases (17.7%). (Fig.?3) In the overall population of STEMI cases, the mean age was 61?years. The majority was male (69.6%) and Caucasian (52%), with 43.8% being African-American. Baseline demographic and clinical characteristics of STEMI patients who underwent PCI in which CHap was used were comparable [http://www.selleckchem.com/products/gsk2656157.html GSK2656157 concentration] to those treated via standard channels of activation. (Table?1) Likewise, [http://en.wikipedia.org/wiki/17-Dimethylaminoethylamino-17-demethoxygeldanamycin 17-DMAG (Alvespimycin) HCl] baseline and angiographic procedural characteristics between groups were very similar. (Table?2) Of note, non-significant trends toward higher incidences of diabetes mellitus and a higher number of lesions treated were present in patients managed via standard channels of activation. In-hospital outcomes are presented in Table?3. None of the evaluated end points differed significantly between groups. An unfavorable trend toward higher in-hospital MACE was present for patients managed via standard channels of activation, contributed by cardiac death, urgent TLR, and the need for coronary artery bypass [http://www.selleckchem.com/products/i-bet151-gsk1210151a.html I-BET151 datasheet] surgery (Table?3). Quality measures evaluating the STEMI system of care are presented in Table?4. When the CHap was utilized to activate the management flow of a possible STEMI case, a significantly shorter DTB time was achieved (CHap 103?minutes, 95% CI [87.0�C118.3] vs. standard 149?minutes, 95% CI [134.0�C164.8], p?